At GeneproDx we aim to transform next generation cancer diagnosis into a simple, fast and seamless process for our patients. By using genomics and artificial intelligence our technology will provide expedited and accurate information that will improve patient outcomes and quality of life. Our platform provides a unique opportunity to develop novel tests that will answer meaningful clinical questions.
Our mission is to provide the best diagnostic certainty to tailor cancer treatment, while helping containing costs and avoid unnecessary treatments that may harm patients. Patients and physicians will be able to make better decisions based on accurate and timely diagnostic testing.
Our mission at GeneproDX is to offer patients with indeterminate thyroid nodules the highest quality of precision medicine through ThyroidPrint.
To be pioneers and leaders in the diagnosis of patients with indeterminate thyroid nodules in Latin America, through permanent innovation and the highest quality standards.